Antiretroviral therapy coverage for PMTCT in Cote d'Ivoire
Cote d'Ivoire: Antiretroviral therapy coverage for PMTCT was 88.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Cote d'Ivoire, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Cote d'Ivoire stood at 88.0%.
That represents a change of down 1.1% on the previous year and up 4.8% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Cote d'Ivoire peaked at 98.0% in 2021 and was at its lowest, 0.0%, in 2000.
That places Cote d'Ivoire 31st out of 84 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Cote d'Ivoire, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 1.0% | — |
| 2002 | 2.0% | +100.0% |
| 2003 | 4.0% | +100.0% |
| 2004 | 6.0% | +50.0% |
| 2005 | 15.0% | +150.0% |
| 2006 | 9.0% | -40.0% |
| 2007 | 17.0% | +88.9% |
| 2008 | 34.0% | +100.0% |
| 2009 | 42.0% | +23.5% |
| 2010 | 46.0% | +9.5% |
| 2011 | 44.0% | -4.3% |
| 2012 | 57.0% | +29.5% |
| 2013 | 72.0% | +26.3% |
| 2014 | 84.0% | +16.7% |
| 2015 | 88.0% | +4.8% |
| 2016 | 87.0% | -1.1% |
| 2017 | 93.0% | +6.9% |
| 2018 | 94.0% | +1.1% |
| 2019 | 88.0% | -6.4% |
| 2020 | 83.0% | -5.7% |
| 2021 | 98.0% | +18.1% |
| 2022 | 95.0% | -3.1% |
| 2023 | 89.0% | -6.3% |
| 2024 | 88.0% | -1.1% |
Cote d'Ivoire compared with similar countries
- Cote d'Ivoire's 88.0% is above the median for lower middle income countries, which is 83.5%, 1.1× the median. (32 countries reporting)
- Cote d'Ivoire's 88.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.1× the median. (41 countries reporting)
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in Cote d'Ivoire changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +150.0% | 6.0% | 15.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 13.0% | 0.0% | 42.0% | 10 |
| 2010s | 75.3% | 44.0% | 94.0% | 10 |
| 2020s | 90.6% | 83.0% | 98.0% | 5 |
Countries ranked near Cote d'Ivoire
More health data for Cote d'Ivoire
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7342 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 864.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 32,592 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 12 (2025)
- Population ages 00-04, female, annual growth rate 1.01 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.04 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Cote d'Ivoire?
- Antiretroviral therapy coverage for pmtct in Cote d'Ivoire was 88.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Cote d'Ivoire?
- The highest recorded value was 98.0% in 2021.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Cote d'Ivoire?
- The lowest recorded value was 0.0% in 2000.
- How does Cote d'Ivoire rank for antiretroviral therapy coverage for pmtct?
- Cote d'Ivoire ranks 31st out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Cote d'Ivoire?
- Over the last ten years it is up 4.8%. The long-run trend across the full record is volatile.
- Where does this Cote d'Ivoire data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).